# TOLLIP

## Overview
TOLLIP (toll interacting protein) is a gene that encodes an intracellular adaptor protein involved in the regulation of immune responses and cellular homeostasis. The TOLLIP protein is characterized by its role in mediating inflammatory pathways, autophagy, and protein trafficking. It contains several conserved domains, including the Tom1 binding domain (TBD), the C2 domain, and the coupling of ubiquitin to endoplasmic reticulum degradation (CUE) domain, which facilitate its interactions with various proteins and phospholipids. These interactions are crucial for its function in pathways such as those involving interleukin receptors and toll-like receptors, as well as in mitochondrial quality control and autophagy. TOLLIP's involvement in these processes underscores its significance in maintaining cellular function and its potential implications in various diseases, including idiopathic pulmonary fibrosis, infectious diseases, and neurodegenerative disorders (Ciarrocchi2009Tollip; Ryan2020Tollip; Li2020Tollinteracting).

## Structure
The TOLLIP protein is characterized by several conserved domains that contribute to its function in immune response regulation. It contains an N-terminal Tom1 binding domain (TBD), a central C2 domain, and a C-terminal coupling of ubiquitin to endoplasmic reticulum degradation (CUE) domain (Ciarrocchi2009Tollip; Ghani2021Identification). The C2 domain is involved in phospholipid binding, which is crucial for its role in cellular signaling pathways (Ciarrocchi2009Tollip). The CUE domain facilitates interactions with ubiquitinated proteins, playing a role in protein sorting and degradation (Ghani2021Identification).

The secondary structure of TOLLIP includes alpha helices and beta sheets, which are typical of proteins involved in complex signaling pathways (Ciarrocchi2009Tollip). TOLLIP undergoes post-translational modifications such as phosphorylation, which can affect its structure and function (Ghani2021Identification). These modifications are important for the regulation of its activity and interactions with other proteins.

TOLLIP's structure allows it to interact with various proteins involved in immune signaling, including those in the sumoylation pathway, highlighting its role as a mediator in protein modification processes (Ciarrocchi2009Tollip).

## Function
TOLLIP (toll interacting protein) is an intracellular adaptor protein that plays a significant role in various cellular processes in healthy human cells. It is involved in mediating inflammatory responses, promoting autophagy, and facilitating vacuole trafficking. TOLLIP is part of multiple signaling pathways, including those involving interleukin (IL)-1β, IL-13, toll-like receptor (TLR) 2 and 4, and transcription growth factor (TGF)-β. Structurally, TOLLIP has three domains: the target of Myb (TOM) binding domain (TBD), the conserved 2 (C2) domain, and the coupling of ubiquitin to ER degradation (CUE) domain. Each domain contributes to TOLLIP's functions. The TBD domain is involved in endosomal sorting by recruiting TOM1 and clathrin. The C2 domain is responsible for phosphoinositide binding and localization to phospholipid-rich membranes, which is crucial for autophagy. The CUE domain enhances binding to ubiquitin chains and is necessary for interactions with cell surface receptors, such as IL-1 receptor-1, TLR2, TLR4, and TGF-β receptor 1 (Li2020Tollinteracting).

TOLLIP also plays a role in the cGAS-STING pathway, acting as a stabilizer to prevent STING activation and related inflammatory cascades (Li2020Tollinteracting). It is involved in the regulation of autophagy, a process essential for cellular homeostasis and longevity (Li2020Tollinteracting).

## Clinical Significance
Mutations and alterations in the expression of the TOLLIP gene have significant clinical implications across various diseases. In idiopathic pulmonary fibrosis (IPF), TOLLIP expression is generally reduced, contributing to disease progression by increasing epithelial cell susceptibility to apoptosis. Specific single nucleotide polymorphisms (SNPs) within the TOLLIP locus, such as rs111521887 and rs5743894, are associated with increased susceptibility to IPF, while rs5743890 is protective against disease onset but linked to higher mortality in affected individuals (Li2021TollInteracting; Li2020Toll).

In the context of infectious diseases, TOLLIP plays a role in modulating immune responses. For instance, the rs5743854 SNP is associated with decreased TOLLIP expression and increased resistance to Legionnaires' disease by enhancing pro-inflammatory responses (Shah2019TOLLIP). In tuberculosis, TOLLIP SNPs such as rs5743899 and rs3750920 influence susceptibility by altering gene expression levels in monocytes (Li2021TollInteracting).

TOLLIP is also implicated in neurodegenerative diseases, where its dysregulation is linked to inflammation and autophagy dysfunction, contributing to conditions like Parkinson's and Alzheimer's diseases (Li2020Tollinteracting). These findings underscore the gene's complex role in disease susceptibility and progression, highlighting its potential as a target for therapeutic interventions.

## Interactions
TOLLIP (toll interacting protein) is involved in various protein interactions that play significant roles in cellular processes. It interacts with the interleukin-1 receptor accessory protein (IL-1RAcP) to inhibit IL-1β-triggered NF-κB signaling, a key pathway in inflammation (Li2020Tollinteracting). TOLLIP also interacts with PTEN-induced putative kinase 1 (PINK1) to prevent the activation of IRAK-1, thereby reducing the production of inflammatory cytokines such as TNFα and IL-6 (Li2020Tollinteracting).

In the context of mitochondrial quality control, TOLLIP interacts with Parkin, an E3 ubiquitin ligase associated with Parkinson's disease. This interaction is crucial for the trafficking of mitochondrial-derived vesicles (MDVs) to lysosomes, facilitating the clearance of damaged mitochondrial components (Ryan2020Tollip). The interaction between TOLLIP and Parkin is dependent on the CUE domain of TOLLIP, which binds ubiquitin chains (Ryan2020Tollip).

TOLLIP also plays a role in autophagy by binding to ubiquitinated protein aggregates through its CUE domain and interacting with LC3, a central protein in autophagy, to facilitate the clearance of cytotoxic protein aggregates (Li2020Tollinteracting). These interactions highlight TOLLIP's involvement in regulating inflammation, autophagy, and mitochondrial quality control.


## References


[1. (Shah2019TOLLIP) Javeed A. Shah, Robyn Emery, Brian Lee, Sambasivan Venkatasubramanian, Jason D. Simmons, Melanie Brown, Chi F. Hung, Jan M. Prins, Annelies Verbon, Thomas R. Hawn, and Shawn J. Skerrett. Tollip deficiency is associated with increased resistance to legionella pneumophila pneumonia. Mucosal Immunology, 12(6):1382–1390, November 2019. URL: http://dx.doi.org/10.1038/s41385-019-0196-7, doi:10.1038/s41385-019-0196-7. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41385-019-0196-7)

[2. (Li2021TollInteracting) Xiaoyun Li, Gillian C. Goobie, Alyssa D. Gregory, Daniel J. Kass, and Yingze Zhang. Toll-interacting protein in pulmonary diseases. abiding by the goldilocks principle. American Journal of Respiratory Cell and Molecular Biology, 64(5):536–546, May 2021. URL: http://dx.doi.org/10.1165/rcmb.2020-0470TR, doi:10.1165/rcmb.2020-0470tr. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1165/rcmb.2020-0470TR)

[3. (Li2020Toll) Xiaoyun Li, Sharon E. Kim, Ting‐Yun Chen, Juan Wang, Xia Yang, Tracy Tabib, Jiangning Tan, Brandon Guo, Sonia Fung, Jing Zhao, John Sembrat, Mauricio Rojas, Sruti Shiva, Robert Lafyatis, Claudette St. Croix, Jonathan K. Alder, Y. Peter Di, Daniel J. Kass, and Yingze Zhang. Toll interacting protein protects bronchial epithelial cells from bleomycin‐induced apoptosis. The FASEB Journal, 34(8):9884–9898, June 2020. URL: http://dx.doi.org/10.1096/fj.201902636rr, doi:10.1096/fj.201902636rr. This article has 31 citations.](https://doi.org/10.1096/fj.201902636rr)

[4. (Ryan2020Tollip) Thomas A Ryan, Elliott O Phillips, Charlotte L Collier, Alice JB Robinson, Daniel Routledge, Rebecca E Wood, Emelia A Assar, and David A Tumbarello. Tollip coordinates parkin‐dependent trafficking of mitochondrial‐derived vesicles. The EMBO Journal, April 2020. URL: http://dx.doi.org/10.15252/embj.2019102539, doi:10.15252/embj.2019102539. This article has 60 citations.](https://doi.org/10.15252/embj.2019102539)

[5. (Ciarrocchi2009Tollip) Alessia Ciarrocchi, Romina D’Angelo, Chiara Cordiglieri, Ada Rispoli, Spartaco Santi, Massimo Riccio, Simona Carone, Anna Laura Mancia, Simone Paci, Elena Cipollini, Davide Ambrosetti, and Marialuisa Melli. Tollip is a mediator of protein sumoylation. PLoS ONE, 4(2):e4404, February 2009. URL: http://dx.doi.org/10.1371/journal.pone.0004404, doi:10.1371/journal.pone.0004404. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0004404)

6. (Ghani2021Identification) Identification of Most Lethal Non-synonymous SNPs in Tollip gene- An In-Silico Analysis. This article has 0 citations.

[7. (Li2020Tollinteracting) Xiaoyun Li, Gillian C. Goobie, and Yingze Zhang. Toll-interacting protein impacts on inflammation, autophagy, and vacuole trafficking in human disease. Journal of Molecular Medicine, 99(1):21–31, October 2020. URL: http://dx.doi.org/10.1007/s00109-020-01999-4, doi:10.1007/s00109-020-01999-4. This article has 21 citations.](https://doi.org/10.1007/s00109-020-01999-4)